Nutra Pharma Corp (NPHC) Depreciation & Amortization (CF) (2012 - 2018)

Nutra Pharma has disclosed Depreciation & Amortization (CF) across 7 years of filings, most recently posting $1105.0 for Q3 2018.

• In Q3 2018, Depreciation & Amortization (CF) fell 5.39% year-over-year to $1105.0; the TTM figure through Jun 2019 stood at $1105.0 (down 83.72% YoY), while the FY2021 annual figure was $9084.0, up 137.12% from the prior year.
• Depreciation & Amortization (CF) came in at $1105.0 for Q3 2018 at Nutra Pharma, down from $1825.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $4814.0 in Q4 2014 to a low of $1105.0 in Q3 2018.
• Average Depreciation & Amortization (CF) over 5 years is $2510.1, with a median of $2132.0 recorded in 2016.
• Year-over-year, Depreciation & Amortization (CF) tumbled 55.73% in 2015 and soared 32.34% in 2018.
• Over 5 years, Depreciation & Amortization (CF) stood at $4814.0 in 2014, then plunged by 55.73% to $2131.0 in 2015, then grew by 8.4% to $2310.0 in 2016, then fell by 19.26% to $1865.0 in 2017, then slumped by 40.75% to $1105.0 in 2018.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $1105.0 in Q3 2018, $1825.0 in Q2 2018, and $1928.0 in Q1 2018.